4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-011677
EVP, Head of North America sold 5,216 shares at an average $58.64 ($305,846)
- EVP, Head of North America acquired 9,657 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-09 | Option exercise 10b5-1 | +3,437 | 4,409 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-09 | Option exercise 10b5-1 | +4,189 | $6.80 | $28,485 | 8,598 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-10 | Sale 10b5-1 | −1,894 | $58.39 | $110,596 | 6,704 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-10 | Sale 10b5-1 | −2,295 | $59.34 | $136,187 | 4,409 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-11 | Option exercise 10b5-1 | +2,031 | 6,440 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-11 | Sale 10b5-1 | −1,023 | $57.51 | $58,833 | 5,417 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-11 | Sale 10b5-1 | −4 | $57.50 | $230 | 5,413 | D |
| Derivatives | |||||||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-09 | Option exercise · Restricted Stock Units 10b5-1 | −3,437 | 3,437 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,189 | 21,601 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-11 | Option exercise · Restricted Stock Units 10b5-1 | −2,031 | 0 | D | ||
| Open-market sales · 5,216 sh · avg $58.64 · $305,846 | |||||||
Loading xslF345X05/tm256299-3_4seq1.xml…